About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Special Survey Long-term Treatment With Tiotropium on COPD

NCT00638183·89 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Boehringer Ingelheim

Age

20–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Patients of Chronic Obstructive Pulmonary Disease
2. Patients were expected to use the product for long period of time

You may not be if

1. Patients with glaucoma
2. Patients with micturition disorder due to prostatic hyperplasia etc.
3. Patients with a history of hypersensitivity to atropine or its derivatives or to any component of this product

The record

StatusCompleted

PhaseNo phase

Taking part385

StartedApr 2005

UpdatedJun 19, 2014

Conditions

Pulmonary Disease, Chronic Obstructive

Where89

Boehringer Ingelheim Investigational Site
Asahikawa, Japan
Boehringer Ingelheim Investigational Site
Chikushino-shi, Japan
Boehringer Ingelheim Investigational Site
Daitō, Japan

Clareo Health | Special Survey Long-term Treatment With Tiotropium on COPD